Low-doses of beta blockers just as good

SURVIVAL for patients prescribed low doses of beta-blockers following myocardial infarction (MI) are the same or in some cases better than the rates for those taking higher doses, research shows.

A US multicentre, observational study of 7000 post-MI patients showed that the cardiovascular outcomes and all-cause mortality of those taking around 25% of their predicted target beta-blocker dose were no worse than for patients taking 50–100% of their target dose.

The findings support a clinical trend that is already recognised by many frontline practitioners.

“We already know